Title : How to optimize HCV therapy in genotype 2 patients.

Pub. Date : 2013 Feb

PMID : 23286844






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 On the other hand on-treatment HCV RNA kinetics are fundamental for individualized treatment regimens because achieving negative HCV RNA at week 4 (rapid virological response, RVR) is the key factor when the duration of PEG-IFN/RBV is tailored in HCV-2 patients. Ribavirin nuclear receptor subfamily 1 group D member 2 Homo sapiens